HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nadir M Maraldi Selected Research

Laminopathies

2/2018The lamin code.
4/2011Laminopathies and lamin-associated signaling pathways.
1/2011Muscular laminopathies: role of prelamin A in early steps of muscle differentiation.
1/2010Laminopathies and A-type lamin-associated signalling pathways.
9/2009A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward.
2/2008Drugs affecting prelamin A processing: effects on heterochromatin organization.
1/2008SREBP1 interaction with prelamin A forms: a pathogenic mechanism for lipodystrophic laminopathies.
1/2007Prelamin A processing and heterochromatin dynamics in laminopathies.
1/2007A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome.
1/2006Laminopathies: a chromatin affair.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nadir M Maraldi Research Topics

Disease

14Laminopathies
02/2018 - 01/2005
6Muscular Diseases (Myopathy)
12/2016 - 12/2003
4Lipodystrophy
09/2014 - 06/2005
4Mitochondrial Diseases (Mitochondrial Disease)
06/2013 - 01/2007
4Familial Partial Lipodystrophy (Dunnigan Syndrome)
10/2012 - 11/2003
4Muscular Dystrophies (Muscular Dystrophy)
04/2011 - 06/2009
4Inborn Genetic Diseases (Disease, Hereditary)
04/2011 - 01/2005
4Scleroatonic muscular dystrophy
11/2010 - 01/2007
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
06/2013 - 05/2009
3Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
06/2012 - 11/2008
3Bethlem myopathy
11/2010 - 04/2008
1Hematologic Neoplasms (Hematological Malignancy)
08/2013
1Cardiomyopathies (Cardiomyopathy)
06/2012
1Progeria (Hutchinson Gilford Syndrome)
06/2012
1Rare Diseases (Rare Disease)
07/2011
1Starvation
11/2010
1Insulin Resistance
01/2007
1Acute Erythroblastic Leukemia (Erythroleukemia)
11/2006
1Werner Syndrome (Werner's Syndrome)
06/2005
1Neoplasms (Cancer)
12/2004
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
12/2003
1Miyoshi myopathy
12/2003

Drug/Important Bio-Agent (IBA)

9Lamin Type A (Lamin A)IBA
02/2018 - 11/2003
9Proteins (Proteins, Gene)FDA Link
12/2016 - 12/2003
7CollagenIBA
12/2016 - 01/2007
7prelamin AIBA
09/2014 - 06/2005
6LaminsIBA
06/2012 - 11/2003
3Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2009 - 01/2007
2Beclin-1IBA
12/2016 - 11/2010
2Messenger RNA (mRNA)IBA
12/2016 - 11/2009
2DystrophinIBA
06/2013 - 05/2009
2emerinIBA
04/2011 - 11/2003
2Extracellular Matrix ProteinsIBA
06/2009 - 04/2008
2ChromatinIBA
01/2006 - 10/2005
1Apoptosis Regulatory ProteinsIBA
08/2013
1Biomarkers (Surrogate Marker)IBA
06/2013
1Lamin Type B (Lamin B)IBA
04/2011
1Carrier Proteins (Binding Protein)IBA
04/2011
1Peptides (Polypeptides)IBA
04/2011
1Nuclear Matrix-Associated ProteinsIBA
04/2011
1lamina-associated polypeptide 2IBA
04/2011
1Antisense OligonucleotidesIBA
11/2009
1Cyclophilins (Cyclophilin)IBA
06/2009
1Antisense OligoribonucleotidesIBA
05/2009
1Ion Channels (Ion Channel)IBA
04/2008
1CyclosporinsIBA
01/2007
1HeterochromatinIBA
01/2007
1Cyclin D3IBA
11/2006
1RNA Splicing FactorsIBA
11/2006
1PPAR gammaIBA
06/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2005
1Nuclear Proteins (Protein, Nuclear)IBA
05/2005
1CytokinesIBA
12/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2004
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2004
1DysferlinIBA
12/2003

Therapy/Procedure

4Therapeutics
06/2009 - 01/2007
1Protein-Restricted Diet (Diet, Protein Restricted)
12/2016